Search
for
Sort by
Research 61–90 of 673
- HIV Symptom Clusters are Similar Using the Dimensions of Symptom Occurrence and Distress
- Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors
- Depressive and Anxiety Symptoms in Women with Polycystic Ovary Syndrome: A Meta-Analysis
- Age-Related Differences for Male-to-Female Transgender Patients Undergoing Gender-Affirming Surgery
- Commonly encountered symptoms and their management in patients with cirrhosis
- Diagnostic Signs and Symptoms of Cyanocobalamin Deficiency at Rural Setting in India: Novel Method of Supplementation
- Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in Japan
- Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis
- Beyond ECMO Survival: Long-Term Symptom Burden and Quality-of-Life Impairment in Hantavirus Cardiopulmonary Syndrome Survivors
- Reframing the Discussion on Finasteride and Neuropsychiatric Safety
- Public Awareness of the Symptoms and Risk Factors of Thyroid Disease in Saudi Arabia
- Trend and Co-occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
- Body image mediates the impact of pain on depressive symptoms in patients with systemic lupus erythematosus
- Study of item text in the Chinese Symptom Checklist-90
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Time Perspective as a Mediator of Depressive Symptoms in Patients with Polycystic Ovary Syndrome
- Is Withania somnifera (Ashwagandha) a safe and effective treatment for reducing perimenopausal symptoms?
- 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- MULTISYSTEM ADVERSE EFFECTS OF ISOTRETINOIN: MECHANISTIC INSIGHTS AND CLINICAL IMPLICATIONS
- US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know?
- SMART Pharmacists Serving the New Needs of the Post-COVID Patients, Leaving No-One Behind
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications